GSK hands work on potential Ebola vaccines to U.S. institute

British drugmaker GlaxoSmithKline is handing over all its development work on three potential vaccines against the deadly Ebola and Marburg viruses despite an ongoing Ebola outbreak in Democratic Republic of Congo.

from Reuters: Health News https://ift.tt/2Kk1vHK
via IFTTT